Mark J. Feild, Ph.D.
Mark Feild has over 25 years of experience in analytical development, product characterization, product stability, and validation throughout the entire product lifecycle. Mark holds a Ph.D. from North Carolina State University in biochemistry, specializing in protein chemistry.
Mark has experience in both large and small biotechnology and pharmaceutical companies. He has worked in R & D, Process Development, Analytical Development, Quality Control, and Quality Assurance. Most recently, Mark was interim Director of Quality Assurance for NuSil Technology working to implement a cGMP Quality System for a new subsidiary working on a combination product.
In 2005, Mark was co-founder of a contract testing laboratory, WindRose Analytica, Inc. WindRose provided services for analytical program lifecycle development and performed method development, validation, stability and QC testing. Windrose was successfully acquired by Althea Technologies, Inc. in 2009. Mark became Director of Analytical Development for Althea (now known as Ajinomoto Althea, Inc.) where he oversaw all aspects of the department’s management, interfaced with Sales and clients, and remained active at the bench.
Before WindRose, Mark was at Amgen from 1995 to 2005 where he held positions of increasing responsibility in Analytical R & D and Corporate Quality Assurance. His last position was Associate Director of Validation for Corporate Quality. Prior to Amgen, Mark worked at Applied Biosystems, Inc. and La Jolla Pharmaceuticals. His areas of expertise are biomolecule analysis using HPLC, mass spectrometry, electrophoresis (conventional and capillary), spectroscopic analysis (UV, FTIR, CD), light scattering, and immunoblotting.
Email info@pqalliance.com for a detailed description of Mark’s experience.